{"id":19785,"date":"2024-05-29T15:28:13","date_gmt":"2024-05-29T15:28:13","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/?p=19785"},"modified":"2024-05-29T15:31:57","modified_gmt":"2024-05-29T15:31:57","slug":"63rd-afi-symposium-maria-luisa-nollis-interview","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/","title":{"rendered":"63rd AFI Symposium \u2013 Maria Luisa Nolli\u2019s interview"},"content":{"rendered":"<p id=\"tw-target-text\" class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Translation\" aria-label=\"Translated text\" data-ved=\"2ahUKEwjXm72VkrOGAxVdQvEDHWW7DHcQ3ewLegQIFRAU\"><span class=\"Y2IQFc\" lang=\"en\">The <strong>radical innovation of CAR-Ts<\/strong> is changing the prospects for treating onco-haematological diseases with unexpected solutions until a few years ago for pathologies with no other possibility of resolution.<\/span><\/p>\n<p id=\"tw-target-text\" class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Translation\" aria-label=\"Translated text\" data-ved=\"2ahUKEwjHk_6yvLKGAxUw_rsIHRQZArkQ3ewLegQICxAU\"><span class=\"Y2IQFc\" lang=\"en\">The eleventh session of the <strong>63rd AFI Symposium<\/strong>, entitled &#8220;<em>CAR-T: from recent past to near future<\/em>&#8221; and planned for June 6, investigates these aspects through targeted interventions that underline the developments linked to this innovation which is also appearing in <strong>treatment of solid tumors and autoimmune diseases<\/strong>.<\/span><\/p>\n<p>Car-t therefore presents itself as a true revolution in medicine with important challenges and opportunities to be faced for all the actors involved, from the scientific community, to companies, to regulatory institutions.<\/p>\n<p>As <strong>Maria Luisa Nolli<\/strong>, Coordinator of Biotechnology Study Groups of AFI and moderator of the session, reminds us during our interview, it is important to <strong>encourage discussion between the various stakeholders involved<\/strong> in consideration of the enormous impact that this type of methodology could have on the <strong>treatment of rare diseases<\/strong>. Precisely for this reason, a round table was planned during the session, which, thanks to the professionals present, will investigate the <strong>challenges and opportunities of CAR-Ts<\/strong>.<\/p>\n<p><iframe loading=\"lazy\" title=\"63\u00b0 Simposio AFI_Intervista Maria Luisa Nolli\" width=\"696\" height=\"392\" src=\"https:\/\/www.youtube.com\/embed\/or39QmfJQWg?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The eleventh session of the 63\u00b0 AFI Symposium will be dedicated to the radical innovation of CAR-Ts for the treatment of solid tumors and autoimmune diseases.<\/p>\n","protected":false},"author":4,"featured_media":19788,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[1065],"tags":[],"class_list":{"0":"post-19785","1":"post","2":"type-post","3":"status-publish","4":"format-video","5":"has-post-thumbnail","7":"category-afi-interview","8":"post_format-post-format-video"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>63rd AFI Symposium \u2013 Maria Luisa Nolli\u2019s interview<\/title>\n<meta name=\"description\" content=\"The XI session of the AFI Symposium will be dedicated to the innovation of CAR-Ts for the treatment of solid tumors and autoimmune diseases\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"63rd AFI Symposium \u2013 Maria Luisa Nolli\u2019s interview\" \/>\n<meta property=\"og:description\" content=\"The XI session of the AFI Symposium will be dedicated to the innovation of CAR-Ts for the treatment of solid tumors and autoimmune diseases\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-29T15:28:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-29T15:31:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/NOLLI.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Simone Montonati\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simone Montonati\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/\"},\"author\":{\"name\":\"Simone Montonati\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a6fdb39155f21340fe31b3ebcf0ecdcb\"},\"headline\":\"63rd AFI Symposium \u2013 Maria Luisa Nolli\u2019s interview\",\"datePublished\":\"2024-05-29T15:28:13+00:00\",\"dateModified\":\"2024-05-29T15:31:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/\"},\"wordCount\":199,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/NOLLI.png\",\"articleSection\":[\"AFI Interview\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/\",\"name\":\"63rd AFI Symposium \u2013 Maria Luisa Nolli\u2019s interview\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/NOLLI.png\",\"datePublished\":\"2024-05-29T15:28:13+00:00\",\"dateModified\":\"2024-05-29T15:31:57+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a6fdb39155f21340fe31b3ebcf0ecdcb\"},\"description\":\"The XI session of the AFI Symposium will be dedicated to the innovation of CAR-Ts for the treatment of solid tumors and autoimmune diseases\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/NOLLI.png\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/NOLLI.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"63rd AFI Symposium \u2013 Maria Luisa Nolli\u2019s interview\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a6fdb39155f21340fe31b3ebcf0ecdcb\",\"name\":\"Simone Montonati\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/2123f2fad86efe781cc2b3b753a84160f22a16f288a2a6462c482c735ca01425?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2123f2fad86efe781cc2b3b753a84160f22a16f288a2a6462c482c735ca01425?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2123f2fad86efe781cc2b3b753a84160f22a16f288a2a6462c482c735ca01425?s=96&d=mm&r=g\",\"caption\":\"Simone Montonati\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/simone-montonati\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"63rd AFI Symposium \u2013 Maria Luisa Nolli\u2019s interview","description":"The XI session of the AFI Symposium will be dedicated to the innovation of CAR-Ts for the treatment of solid tumors and autoimmune diseases","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/","og_locale":"en_US","og_type":"article","og_title":"63rd AFI Symposium \u2013 Maria Luisa Nolli\u2019s interview","og_description":"The XI session of the AFI Symposium will be dedicated to the innovation of CAR-Ts for the treatment of solid tumors and autoimmune diseases","og_url":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2024-05-29T15:28:13+00:00","article_modified_time":"2024-05-29T15:31:57+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/NOLLI.png","type":"image\/png"}],"author":"Simone Montonati","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Simone Montonati","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/"},"author":{"name":"Simone Montonati","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a6fdb39155f21340fe31b3ebcf0ecdcb"},"headline":"63rd AFI Symposium \u2013 Maria Luisa Nolli\u2019s interview","datePublished":"2024-05-29T15:28:13+00:00","dateModified":"2024-05-29T15:31:57+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/"},"wordCount":199,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/NOLLI.png","articleSection":["AFI Interview"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/","url":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/","name":"63rd AFI Symposium \u2013 Maria Luisa Nolli\u2019s interview","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/NOLLI.png","datePublished":"2024-05-29T15:28:13+00:00","dateModified":"2024-05-29T15:31:57+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a6fdb39155f21340fe31b3ebcf0ecdcb"},"description":"The XI session of the AFI Symposium will be dedicated to the innovation of CAR-Ts for the treatment of solid tumors and autoimmune diseases","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/NOLLI.png","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/NOLLI.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-maria-luisa-nollis-interview\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"63rd AFI Symposium \u2013 Maria Luisa Nolli\u2019s interview"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a6fdb39155f21340fe31b3ebcf0ecdcb","name":"Simone Montonati","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/2123f2fad86efe781cc2b3b753a84160f22a16f288a2a6462c482c735ca01425?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2123f2fad86efe781cc2b3b753a84160f22a16f288a2a6462c482c735ca01425?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2123f2fad86efe781cc2b3b753a84160f22a16f288a2a6462c482c735ca01425?s=96&d=mm&r=g","caption":"Simone Montonati"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/simone-montonati\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/19785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=19785"}],"version-history":[{"count":5,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/19785\/revisions"}],"predecessor-version":[{"id":19813,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/19785\/revisions\/19813"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/19788"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=19785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=19785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=19785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}